Achillion Pharmaceuticals, Inc. (ACHN)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.35 / 7.01
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

4 Biotech Stocks on the Move

4 Biotech Stocks on the Move

These four biotech stocks have been moving on some interesting news and clinical results.

Anchillion upgraded at JMP

Bears Must Bear With Upward Drift

Bears Must Bear With Upward Drift

The upside may look limited here, but it is not easy to fight.

Logic Has Nothing to Do With This Market

There really is no such thing as "bad news" right now because there are buyers regardless.

Nothing for Bears to Get Excited About

Nothing for Bears to Get Excited About

Market has been slow but steady with no overtly negative action.

Market Advantage Shifts to the Pessimists

Buyers don't have much staying power.

Virgin America May Finally Be Ready to Leave the Gate (Plus: PE, GE, CPE, ACHN)

Virgin America May Finally Be Ready to Leave the Gate (Plus: PE, GE, CPE, ACHN)

We would look to go long VA on a $39 buy-stop using a $34 sell-stop. 

Achillion upgraded at William Blair

Develop Biotech 'Buy-Sell' Strategy

Develop Biotech 'Buy-Sell' Strategy

When to take profits is a tricky but important decision.

Achillion downgraded at Baird

A Biotech With Enormous Potential

A Biotech With Enormous Potential

The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.

Two Small-Cap Biotechnology Gems

Two Small-Cap Biotechnology Gems

For speculative investors.

Off the Charts

Off the Charts

We're establishing a new position in Zillow, and making a number of other adjustments.

A Step in the Right Direction

But the market still has more work to do.

The Trader Daily

The Trader Daily

The iShares Transportation Average (IYT) is one to watch.

The Trader Daily

The Trader Daily

Focus on buying the dip for IWM. 

The Trader Daily

The Trader Daily

There's plenty of opportunity despite the low volume.

The Trader Daily

The Trader Daily

Forget market chatter, just focus on price.

Playing the New Hepatitis C Drugs

Playing the New Hepatitis C Drugs

There has been huge progress in treating this lethal disease.

The Trader Daily

The Trader Daily

A bias between neutral and bullish is most appropriate.

The Trader Daily

The Trader Daily

Corn is still in a horrific bear market.

The Trader Daily

The Trader Daily

I suggest you add CORN to your screen.

And We're Off!

Here we go. By Bret Jensen The market is slightly up across the board in the first 30 minutes of trading, and the 10-year Treasury yield is approaching 2.65%. Deckers Outdoor (DECK) is nicely up due to an upgrade at Wells Fargo, which now has price ...

Politics Push Stock Plunger

Politics Push Stock Plunger

Political squabbling in the U.S. and in Italy has pushed stocks down globally. Achillion Pharma plunges as Apple Beats Coke on branding.

Biotech's Next Big Thing: Fall Trials

Biotech's Next Big Thing: Fall Trials

Its been a busy summer for biotech, but the coming weeks will heat up with trials from Biodel, Achillon and Coronado, says Adam Feuerstein, Sr. Columnist at TheStreet.